Literature DB >> 2557044

Regulation of human synovial fibroblast collagenase messenger RNA by interleukin-1.

S S McCachren1, P K Greer, J E Niedel.   

Abstract

Interleukin-1 (IL-1) may contribute to tissue destruction in rheumatoid arthritis, in part, by inducing messenger RNA (mRNA) that encodes interstitial collagenase. In human synovial fibroblasts in vitro, IL-1 induced collagenase mRNA accumulation 6 hours after being added to the cells. High levels of mRNA remained present for at least 48 hours after treatment. The rate of transcription of collagenase in isolated nuclei peaked after approximately 6 hours of treatment with IL-1 and declined thereafter, becoming nearly undetectable by 24 hours. The persistence of mRNA, in view of the transient peak of transcription, suggested that collagenase mRNA was stable in synovial fibroblasts. The half-life of collagenase mRNA after the synoviocytes were treated with actinomycin D was approximately 27 hours, both in the presence and in the absence of IL-1. It has been noted that induction of the expression of collagenase by phorbol esters requires fos protein synthesis and is mediated through a tetradecanoyl phorbol acetate response element in the 5'-flanking region of the gene. However, we found that cycloheximide, when added to synovial fibroblast cultures up to 6 hours after treatment with IL-1, inhibited the expression of collagenase mRNA. These results suggest that fos alone is unlikely to be sufficient for collagenase expression, and that additional factors, or alternative pathways, are involved in the induction of collagenase by IL-1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557044     DOI: 10.1002/anr.1780321207

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

Authors:  Z Szekanecz; A E Koch; S L Kunkel; R M Strieter
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

2.  An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.

Authors:  E Haker; E Theodorsson; T Lundeberg
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

3.  Expression of CD44 variants in human inflammatory synovitis.

Authors:  L P Hale; B F Haynes; S S McCachren
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

4.  Heat shock of human synovial and dermal fibroblasts induces delayed up-regulation of collagenase-gene expression.

Authors:  E G Hitraya; J Varga; S A Jimenez
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

5.  Basement membrane proteins in synovial membrane: distribution in rheumatoid arthritis and synthesis by fibroblast-like cells.

Authors:  M Schneider; B Voss; J Rauterberg; M Menke; T Pauly; R K Miehlke; J Friemann; U Gerlach
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

6.  Differential regulation of collagenase gene expression by retinoic acid receptors--alpha, beta and gamma.

Authors:  L Pan; S H Chamberlain; D T Auble; C E Brinckerhoff
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

7.  Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.

Authors:  S Maeda; T Sawai; M Uzuki; Y Takahashi; H Omoto; M Seki; M Sakurai
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

8.  Interleukin 1 induces the expression of a heat-shock gene in chondrocytes.

Authors:  T F Cruz; R A Kandel; I R Brown
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

9.  Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms.

Authors:  M P Vincenti; C I Coon; O Lee; C E Brinckerhoff
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

10.  Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate.

Authors:  P L van Lent; L van den Bersselaar; A E van den Hoek; M van de Ende; C D Dijkstra; N van Rooijen; L B van de Putte; W B van den Berg
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.